Skip to main content
. Author manuscript; available in PMC: 2025 May 1.
Published in final edited form as: Adv Drug Deliv Rev. 2024 Mar 5;208:115237. doi: 10.1016/j.addr.2024.115237

Table 2.

Common 3D bioprinting modalities.

3D bioprinting modality Description Resolution range Advantages Disadvantages Applications Refs.
Conventional extrusion bioprinting Compressed air or mechanical screw or piston drives the bioink through a nozzle 100–2000 μm Multi-material bioprinting; high scalability; high cell density; cost-effective Nozzle clogging; moderate cell viability due to shear stress To biofabricate 3D tissue structures in a layer-by-layer manner [247, 248, 265267]
Co-axial bioprinting Simultaneous extrusion of bioinks and crosslinker solution through coaxial nozzle 200–2000 μm Complex setup; challenges in tuning flow rates for each bioink simultaneously To biofabricate standalone solid or hollow tubular fibers [249, 268272]
Embedded bioprinting Extrusion of bioink into supportive bath into a support bath that holds the bioprinted structure. ~20 μm Challenges in removal of support matrix; may require additional processing steps To biofabricate complex tissue structures using mechanically weak bioinks [249, 276279, 283]
Chaotic bioprinting Chaotic flow of two or more bioinks using a nozzle equipped with a Kenics static mixer ~10 μm Nozzle clogging; moderate cell viability due to shear stress; not suitable for high-viscosity bioinks To generate continuous fibers with internally aligned lamellar microstructures [294, 295, 300302]
Inkjet-based bioprinting Electrically heated printhead or piezoelectric actuator ejects small droplets of bioink out of the nozzle ~50 μm High bioprinting speed; precise deposition of bioink droplets; cost-effective Low cell viability; non-uniform droplets; printhead clogging; requires low cell density and low viscosity bioinks To biofabricate tissue scaffolds by precise placement of small droplets of bioink onto a substrate [250, 303305, 308, 312, 314316]
Stereolithography Either single- or two-photon laser and raster scanning selectively that cures a bioink in a point-by-point manner ~1 μm Nozzle-free; relatively fast bioprinting speed; high cell viability Requires photocurable bioinks; moderate cost To biofabricate tissue structures by exposing bioink to the laser that selectively cures a bioink in a point-by-point manner [317320]
Digital light processing Either UV or visible light prepatterned from a projector selectively that cures the bioink in a layer-by-layer manner ~35–100 μm To biofabricate tissue structures by exposing light through a digital mask or pattern onto the surface of the bioink in a layer-by-layer manner [256, 318, 329, 330]
Volumetric bioprinting Simultaneous exposure of UV or visible light onto a rotating vat of bioink that creates a desired structure in a single step ~40–100 μm To biofabricate geometrically complex tissue construct in a centimeter-scale in a single step. [253, 336339]
Laser-assisted bioprinting Precise deposition of the bioink onto a substrate using laser pulses ~10–100 μm High precision; relatively fast bioprinting speed; high cell density Limited cell viability; requires high-viscosity bioinks; comparatively high cost To facilitate tissue regeneration via bioprinting using single cells or cell aggregates [258, 345, 351, 352]
Kenzan bioprinting Precise positioning of spheroids within a microneedle array to fused into tissue constructs Spheroids of ~500 μm in diameter are fused to form larger tissue constructs High cell density; high cell viability; may not require supporting biomaterial scaffold Requires pre-fabrication of spheroids; complex bioprinting setup; may induce damage due to needle To biofabricate tissue structures utilizing cell spheroids as the fundamental building blocks [262, 356, 357]